Literature DB >> 16305435

Lipid-core micelles for targeted drug delivery.

Vladimir P Torchilin1.   

Abstract

Micelles, self-assembling nanosized colloidal particles with a hydrophobic core and hydrophilic shell are currently successfully used for the solubilization of various poorly soluble pharmaceuticals and demonstrate a series of attractive properties as drug carriers. Polymeric micelles, i.e. micelles formed by amphiphilic block co-polymers possess high stability both in vitro and in vivo and good biocompatibility. Among those micelles, lipid-core micelles, i.e. micelles formed by conjugates of soluble copolymers with lipids (such as polyethylene glycol-phosphatidyl ethanolamine conjugate, PEG-PE) are of special interest. These micelles can effectively solubilize a broad variety of poorly soluble drugs (anticancer drugs in particular) and diagnostic agents. Drug-loaded lipid-core micelles can spontaneously target body areas with compromised vasculature (tumors, infarcts) via the enhanced permeability and retention (EPR) effect. Lipid-core mixed micelles containing certain specific components (such as positively charged lipids) are capable of escaping endosomes delivering incorporated drugs directly into the cell cytoplasm. Various specific targeting ligand molecules (such as antibodies) can be attached to the surface of the lipid-core micelles and bring drug-loaded micelles to and into target cells. Lipid-core micelles carrying various reporter (contrast) groups may become the imaging agents of choice in different imaging modalities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305435     DOI: 10.2174/156720105774370221

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  29 in total

1.  Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.

Authors:  Nilesh Gupta; Hany M Ibrahim; Fakhrul Ahsan
Journal:  J Pharm Sci       Date:  2014-09-29       Impact factor: 3.534

2.  Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.

Authors:  Nadia Anikeeva; Yuri Sykulev; Edward J Delikatny; Anatoliy V Popov
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

3.  Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.

Authors:  Patty Wong; Lin Li; Junie Chea; Melissa K Delgado; Erasmus Poku; Barbara Szpikowska; Nicole Bowles; Megan Minnix; David Colcher; Jeffrey Y C Wong; John E Shively; Paul J Yazaki
Journal:  Cancer Biother Radiopharm       Date:  2017-09       Impact factor: 3.099

4.  Cabozantinib Loaded DSPE-PEG2000 Micelles as Delivery System: Formulation, Characterization and Cytotoxicity Evaluation.

Authors:  Qiuhong Yang; Ryan Moulder K; Mark S Cohen; Shuang Cai; Laird M Forrest
Journal:  BAOJ Pharm Sci       Date:  2015-01-05

5.  Preparation of a novel lipid-core micelle using a low-energy emulsification method.

Authors:  Hans F Fritz; Andrea C Ortiz; Sitaram P Velaga; Javier O Morales
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 6.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

7.  Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity.

Authors:  Rupa R Sawant; Onkar Vaze; Gerard G M D'Souza; Karen Rockwell; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2010-08-21       Impact factor: 4.200

8.  Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.

Authors:  Robert Riehle; Bhushan Pattni; Aditi Jhaveri; Abhijit Kulkarni; Ganesh Thakur; Alexei Degterev; Vladimir Torchilin
Journal:  Pharm Res       Date:  2016-03-07       Impact factor: 4.200

9.  Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.

Authors:  Rupa R Sawant; Rishikesh M Sawant; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-04-29       Impact factor: 5.571

Review 10.  Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

Authors:  Alexander Koshkaryev; Rupa Sawant; Madhura Deshpande; Vladimir Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2012-09-03       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.